Intarcia Therapeutics

Discussion in 'Intarcia Therapeutics' started by anonymous, Mar 31, 2017 at 10:22 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Too funny. :D Which WS firm expects this flim-flam outfit to sell $600 million in the initial 2 quarters?

    The only disruption for ITCA getting shafted again by FDA and NO reimbursement by the payors for the first year and beyond, moron.
     

  2. anonymous

    anonymous Guest

    Sounds like more scraps are being built at Hayward? Will they pass stability and sterility this time? FDA OK with not doing another round of clinical trials and in-vitro comparability studies with essentially new ITCA?
     
  3. anonymous

    anonymous Guest

    Our launch will be the biggest event in Pharmaceutical news in 2020. The American Diabetes Association reports that, as of 2015, in the United States alone 30.3 Million individuals have Diabetes. Our Medici platform is expected to achieve a peak annual patient share of 4-6.5 Million patients within 3 years of launch. With our once a year Medici implant coming to market at an expected $30K per patient per year, our peak sales could be as high as $195T - our plan will be to discount based on manufacturing volume and land sustainable annual sales of $5 Billion or more in the US alone. Our partner Servier is expected to deliver a similar revenue stream in their licensed territories.

    Our manufacturing delays have all been resolved so we can now produce the 3 million pumps needed to achieve our year 1 launch goals.

    The 2017 Form 483 observations the Business Journal reported previously have all been remediated and the site is manufacturing product under those conditions. It is important to clarify that the prior Form 483 observations, which were identified during a 2017 pre-approval inspection of our Hayward manufacturing site, were not findings of any actual product contamination … These were observations by the (FDA) that needed to be addressed in order to approve the commercial readiness of our facility,” Intarcia said in a statement.

     
  4. anonymous

    anonymous Guest

    Moron, isn't it too early for the bong hits?
     
  5. anonymous

    anonymous Guest

    Stay tuned news coming. Much flurry of activity because of importance. Will have to announce shortly
     
  6. anonymous

    anonymous Guest

    Fucking shit show melt down. If you,re riffed don’t be surprised.
     
  7. anonymous

    anonymous Guest

    whats going on?
     
  8. anonymous

    anonymous Guest

    Intarcia has become the laughing stock at JPM since 2018. There are hundreds of new exciting drugs being pitched and they can't even get a generic drug inside 25 yr old device approved yet they keep on lying about launching non-existent 1-yr implant making billions and disrupt the type II diabetes franchise.
     
  9. anonymous

    anonymous Guest

    Synthetic royalties for sale ! Come get your Synthetic Royalties ! Theres a sucker born every minute. How stupid do they have to be to buy the disruptive bullshit story
     
  10. anonymous

    anonymous Guest

    Too much on the line - what did the FDA say ? I've heard about the scramble are we losing our jobs ?
     
  11. anonymous

    anonymous Guest

    is there a new tune ???
     
  12. anonymous

    anonymous Guest

    Just line up and bend over with a lube of your choice you stupid MFer to be still at that bath-house.
     
  13. anonymous

    anonymous Guest

    Here we go again
     
  14. anonymous

    anonymous Guest

    WTF why cant we just hear the straight truth instead of all these rumors. What tha F*CK happened ???????
     
  15. anonymous

    anonymous Guest

    FDA says go eat sxit and die MFers cuz your resubmission sucks!
     
  16. anonymous

    anonymous Guest

    Hoping to hear the straight truth you say? Well here it is, You're fired! :eek:
     
  17. anonymous

    anonymous Guest

    Crickets say RIF around the corner.
     
  18. anonymous

    anonymous Guest

    Last year set a new record for Biotech Bankruptcies. This Donki-corn (bs valuation + run by jackass) will be going up in flames this year. Two rejections for the same stupid generic drug is a record for incompetence.
     
  19. anonymous

    anonymous Guest

    America's Richest Entrepreneurs Under 40 2016

    Four others from the 2015 ranks stumbled badly (including one who would have aged out anyway) and fell way below even the reduced cut off. They include Theranos’ Elizabeth Holmes, whose net worth is now estimated around zero

    Theranos the other bay area disruptive unicorn led by a narcissist sets the road map for what comes next
     
  20. anonymous

    anonymous Guest

    Excrements about to hit the fan. Get the hell out while you can, all you losers who stayed on.